Balyasny Asset Management
CORZ

Balyasny Asset Management’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Balyasny Asset Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,442
Closed -$20K – 3413
2022
Q2 		$20K Buy
+13,442
New +$61.8K ﹤0.01% 2492
2021
Q4 		– Sell
-150,000
Closed -$1.52M – 2716
2021
Q3 		$1.52M Hold
150,000
– – 0.01% 1206
2021
Q2 		$1.48M Buy
+150,000
New +$1.48M 0.01% 1118

Other funds holding CORZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
JWM
JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Balyasny Asset Management's CORZ Position: Q3 2022 in Review

Balyasny Asset Management sold out of Core Scientific, Inc. Common Stock (CORZ) in Q3 2022, closing a stake of 13,442 shares — an estimated $20K sold.

Balyasny Asset Management first reported a position in CORZ in Q2 2021 and held it in 3 quarters. The position peaked at $1.52M in Q3 2021. 137 funds tracked by Wall St. Rank hold CORZ as of Q3 2022.

  • Balyasny Asset Management reported no remaining Core Scientific, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 13,442 Core Scientific, Inc. Common Stock shares in Q3 2022, an estimated $20K.
  • Balyasny Asset Management first reported a position in Core Scientific, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Balyasny Asset Management's Core Scientific, Inc. Common Stock position peaked at $1.52M in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q3 2022.

Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.